You just read:

U.S. FDA Approves XARELTO® (rivaroxaban) to Help Prevent Blood Clots in Acutely Ill Medical Patients

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Oct 14, 2019, 08:30 ET